Trial intelligence / Profile preview

Methadone vs Morphine for Cancer Pain

NCT00573937Phase 2Terminated

Sponsor
Mayo Clinic
Start
Aug 2007
Primary completion
Apr 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of methadone in cancer pain (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in Numeric Pain Scale Score at Week 4. Started Aug 2007; status: terminated.

02

Drugs

methadone
03

Conditions

cancer pain

Beyond the preview

Go deeper on NCT00573937.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00573937.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call